Overview

Na-Phenylbutyrate VAscular Trial

Status:
NOT_YET_RECRUITING

Trial end date:
2028-01-01

Target enrollment:

Participant gender:

Summary

This study will investigate if the drug sodium phenylbutyrate (NaPB) impacts blood pressure and vascular function in healthy volunteers and in patients with diabetes.

Phase:

EARLY_PHASE1

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

4-phenylbutyric acid